SHORT RHHBY ( ROCHE), SHORT AMLN (AMYLIN)
Roche’s acquisition of DNA ( Genentech ) shows change of the company’s long practiced successful strategy by the new CEO. This indicates lack of confidence in the prior strategy. The new strategy is in reality integration of autonomous subsidiaries, although Roche does not characterize this way. We believe there will
July 21, 2008